This study is about the efficacy of antibiotics and their combinations with adjuvants which are usually prescribed to treat infections and in the treatment of the severe infections called sepsis, so as to improve the quality of treatment in future.
Phase 4
- Conditions
- Health Condition 1: B968- Other specified bacterial agents as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2023/07/055896
- Lead Sponsor
- care hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
BMI <35
Patients with Sepsis or high suspicion of sepsis
Exclusion Criteria
Refuse to participate, withdraw of consent during study time.
Age <18y & >80yrs
Pregnancy, palliative care patients,
Severe oliguric AKI at presentation or AKI on DAY 1 or Day 2 of ICU stay.
BMI >30
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method